215 related articles for article (PubMed ID: 27651009)
21. Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention.
Beier MT
Pharmacotherapy; 2007 Mar; 27(3):399-411. PubMed ID: 17316151
[TBL] [Abstract][Full Text] [Related]
22. Incidence of cholinergic and memantine treatment in Alzheimer's disease in Finland.
Virta L; Viramo P
J Am Geriatr Soc; 2007 Nov; 55(11):1886-7. PubMed ID: 17979907
[No Abstract] [Full Text] [Related]
23. Combination therapy no advantage in Alzheimer's treatment.
Harv Health Lett; 2012 Jun; 37(8):8. PubMed ID: 22774260
[No Abstract] [Full Text] [Related]
24. Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.
Grossberg GT; Edwards KR; Zhao Q
J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):17S-26S. PubMed ID: 16809811
[TBL] [Abstract][Full Text] [Related]
25. Treatment of Alzheimer disease.
Winslow BT; Onysko MK; Stob CM; Hazlewood KA
Am Fam Physician; 2011 Jun; 83(12):1403-12. PubMed ID: 21671540
[TBL] [Abstract][Full Text] [Related]
26. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
27. Retrospective study on the benefits of combined Memantine and cholinEsterase inhibitor treatMent in AGEd Patients affected with Alzheimer's Disease: the MEMAGE study.
Gareri P; Putignano D; Castagna A; Cotroneo AM; De Palo G; Fabbo A; Forgione L; Giacummo A; Lacava R; Marino S; Simone M; Zurlo A; Putignano S
J Alzheimers Dis; 2014; 41(2):633-40. PubMed ID: 24643135
[TBL] [Abstract][Full Text] [Related]
28. Trends of antidementia drugs use in outpatients with Alzheimer's disease in six major cities of China: 2012-2017.
Yu L; Chen X; Yu Z
Int Clin Psychopharmacol; 2019 Nov; 34(6):312-316. PubMed ID: 31274694
[TBL] [Abstract][Full Text] [Related]
29. Time to Treatment Initiation in People With Alzheimer Disease: A Meta-Analysis of Randomized Controlled Trials.
Tsoi KK; Hirai HW; Chan JY; Kwok TC
J Am Med Dir Assoc; 2016 Jan; 17(1):24-30. PubMed ID: 26392193
[TBL] [Abstract][Full Text] [Related]
30. Activities of daily living in moderate-to-severe Alzheimer disease: an analysis of the treatment effects of memantine in patients receiving stable donepezil treatment.
Feldman HH; Schmitt FA; Olin JT;
Alzheimer Dis Assoc Disord; 2006; 20(4):263-8. PubMed ID: 17132971
[TBL] [Abstract][Full Text] [Related]
31. Alzheimer's disease: early diagnosis and treatment.
Chu LW
Hong Kong Med J; 2012 Jun; 18(3):228-37. PubMed ID: 22665688
[TBL] [Abstract][Full Text] [Related]
32. Characterization of cognitive deficits in a transgenic mouse model of Alzheimer's disease and effects of donepezil and memantine.
Nagakura A; Shitaka Y; Yarimizu J; Matsuoka N
Eur J Pharmacol; 2013 Mar; 703(1-3):53-61. PubMed ID: 23276665
[TBL] [Abstract][Full Text] [Related]
33. Alzheimer's disease: Seeing the signs early.
Leifer BP
J Am Acad Nurse Pract; 2009 Nov; 21(11):588-95. PubMed ID: 19900220
[TBL] [Abstract][Full Text] [Related]
34. Novel disease-modifying therapeutics for the treatment of Alzheimer's disease.
Léger GC; Massoud F
Expert Rev Clin Pharmacol; 2013 Jul; 6(4):423-42. PubMed ID: 23927670
[TBL] [Abstract][Full Text] [Related]
35. Benefits of combined cholinesterase inhibitor and memantine treatment in moderate-severe Alzheimer's disease.
Gauthier S; Molinuevo JL
Alzheimers Dement; 2013 May; 9(3):326-31. PubMed ID: 23110864
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of memantine in moderate-to-severe Alzheimer disease: the evidence to date.
Bullock R
Alzheimer Dis Assoc Disord; 2006; 20(1):23-9. PubMed ID: 16493232
[TBL] [Abstract][Full Text] [Related]
37. I remember.
Ladouceur R
Can Fam Physician; 2006 Feb; 52():155. PubMed ID: 16529383
[No Abstract] [Full Text] [Related]
38. The use of acetyl cholinesterase inhibitors and memantine in nursing home residents.
Gorus E; Van Puyvelde K; Corremans V; Mets T
Acta Clin Belg; 2011; 66(5):361-6. PubMed ID: 22145270
[TBL] [Abstract][Full Text] [Related]
39. Memantine effects measured with the Relevant Outcome Scale for Alzheimer's disease in an open-label, single-arm, multicenter clinical study.
Holthoff V; Ferris S; Gauthier S; Ihl R; Robert P; Winblad B; Sternberg K; Tennigkeit F;
Int J Geriatr Psychiatry; 2013 Feb; 28(2):164-72. PubMed ID: 22492589
[TBL] [Abstract][Full Text] [Related]
40. Memantine versus donepezil in mild to moderate Alzheimer's disease: a randomized trial with magnetic resonance spectroscopy.
Modrego PJ; Fayed N; Errea JM; Rios C; Pina MA; Sarasa M
Eur J Neurol; 2010 Mar; 17(3):405-12. PubMed ID: 19874395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
